Galectin-9 as a predictive marker for the onset of immunerelated adverse effects associated with anti-CCR4 MoAb therapy in patients with adult T cell leukemia

Tareg Omer Mohammed, Haorile Chagan-Yasutan, Yugo Ashino, Wakana Nakayama, Yayoi Takahashi, Taizo Shimomura, Tetsuhiro Fujimoto, Yuko Watanabe, Toshiro Niki, Hitoshi Suzushima, Toshio Hattori

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Galectin-9 as a predictive marker for the onset of immunerelated adverse effects associated with anti-CCR4 MoAb therapy in patients with adult T cell leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds